Pathologic assessment of non-alcoholic fatty liver disease. 2007

Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
Center for Liver Diseases at Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.

Non-alcoholic fatty liver disease (NAFLD) represents one of the most common forms of liver disease and is considered the hepatic manifestation of the metabolic syndrome. Within the NAFLD spectrum, simple steatosis is considered benign, whereas non-alcoholic steatohepatitis (NASH) may progress to cirrhosis. The distinction can be made only by liver biopsy. There is not complete agreement on criteria for diagnosis or the features used for grading and staging lesions. This article reviews some of the studies dealing with the histopathology of NAFLD, with attempts to develop a standardized pathologic scoring system for NASH.

UI MeSH Term Description Entries
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity

Related Publications

Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
September 2012, Revue medicale de Bruxelles,
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
November 2006, Histopathology,
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
December 2014, Hepatology research : the official journal of the Japan Society of Hepatology,
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
November 2020, Chinese medical journal,
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
January 2009, Annals of hepatology,
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
January 2017, Advances in experimental medicine and biology,
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
November 2015, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
February 2005, Hospital medicine (London, England : 1998),
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
January 2009, Annals of hepatology,
Silvia Bondini, and David E Kleiner, and Zachary D Goodman, and Terry Gramlich, and Zobair M Younossi
May 2019, Internal medicine journal,
Copied contents to your clipboard!